Cargando…
慢性髓性白血病患者酪氨酸激酶抑制剂自动停药的多中心回顾性研究
OBJECTIVE: The clinical characteristics and outcomes of patients with chronic myeloid leukemia (CML) who had discontinued tyrosine kinase inhibitors (TKI) therapy were analyzed retrospectively. METHODS: Clinical data of 109 cases of chronic CML patients who had discontinued TKI therapy in seven cent...
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Editorial office of Chinese Journal of Hematology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7348222/ https://www.ncbi.nlm.nih.gov/pubmed/30612400 http://dx.doi.org/10.3760/cma.j.issn.0253-2727.2018.12.005 |
Ejemplares similares
-
儿童慢性髓性白血病酪氨酸激酶抑制剂停药的研究进展
Publicado: (2023) -
BCR-ABL激酶区突变在酪氨酸激酶抑制剂耐药慢性髓性白血病患者中的分布及其影响因素
Publicado: (2020) -
2020年中国慢性髓性白血病患者酪氨酸激酶抑制剂治疗状况调研
Publicado: (2021) -
中国真实世界慢性髓性白血病患者停用酪氨酸激酶抑制剂的观察研究
Publicado: (2022) -
慢性髓性白血病患者酪氨酸激酶抑制剂治疗中发生的PH阴性髓系肿瘤
Publicado: (2019)